MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/00016340701837421

Медицинская библиотека · Acta obstetricia et gynecologica Scandinavica · 2008

Dinoprostone vaginal slow-release system (Propess) compared to expectant management in the active treatment of premature rupture of the membranes at term: impact on maternal and fetal outcomes.

Larrañaga-Azcárate Carlos, Campo-Molina Gema, Pérez-Rodríguez Ana Felicitas, Ezcurdia-Gurpegui Miguel

Сравнительное исследованиеСтатьяПеревод в очереди

Аннотация

BACKGROUND

Retrospective study of 744 women at the Virgen del Camino Hospital in Pamplona concerning two variants for the active treatment of premature rupture of the membranes (PROM). The main purpose of the study was to assess the differences between two variants for the active treatment of PROM at term in pregnant women with negative vaginal-rectal culture screening for Group B Streptococci, and a Bishop test of 4 or less on admission.

METHODS

Retrospective study of 744 patients with single pregnancy at term, PROM, and Bishop test <4. The patients, who were not randomised, were treated with dinoprostone (Propess) or expectant therapy, according to the physician's choice. Induction with oxytocin was started 12 h after PROM. Qualitative data were analysed using the chi(2) test, while quantitative data were analysed using the Student's t-test or the Mann-Whitney U-test according to the distribution of the variables. Regression models were applied to correct the biases caused by confounding variables.

RESULTS

Of the 744 patients, the cervix of 13% was maturated with pericervical dinoprostone, while 87% were subject to expectant management until 12 h after rupture of the membranes. The time of dilation and the time until labour were significantly shorter in the dinoprostone group (p=0.0). The rate of caesarean sections was also lower in the dinoprostone group at 9.3% compared to 17.6% in the expectant management group, reaching statistical significance (p=0.04). There were no differences in the parameters of fetal well being (Apgar and pH).

CONCLUSIONS

The use of therapy with dinoprostone in patients with PROM could be a safe method and more effective than expectant management.

Для цитирования: Larrañaga-Azcárate Carlos, Campo-Molina Gema, Pérez-Rodríguez Ana Felicitas, Ezcurdia-Gurpegui Miguel. Dinoprostone vaginal slow-release system (Propess) compared to expectant management in the active treatment of premature rupture of the membranes at term: impact on maternal and fetal outcomes.. Acta obstetricia et gynecologica Scandinavica. 2008. DOI: 10.1080/00016340701837421.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.